COL-3-Induced Molecular and Ultrastructural Alterations in K562 Cells

Mona Fares1,2, Sandra Oerther1,2, Kjell Hultenby3

  • 1Experimental Cancer Medicine, Division of Biomolecular and Cellular Medicine (BCM), Department of Laboratory Medicine, Novum, Karolinska Institutet, 141 57 Huddinge, Sweden.

Summary

Tetracycline-3 (COL-3) triggers chronic myeloid leukemia cell death through DNA damage and organelle disruption. This non-antibiotic compound induces programmed necrosis and paraptosis, offering a novel therapeutic avenue.

Related Concept Videos